General Information of This Metabolic Reaction (MR) (ID:
MR002222) |
Formula |
Reactant |
Salmeterol xinafoate |
Product |
Salmeterol O-dealkylated metabolite |
Reactant Info
|
Product Info
|
Metabolic Type
|
Oxidation
-
O-Dealkylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Determination of salmeterol, -hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS. Biomed Chromatogr. 2021 Aug;35(8):e5114. doi: 10.1002/bmc.5114.
|
2 |
Pharmacokinetics of salmeterol and its main metabolite -hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control. Drug Test Anal. 2021 Apr;13(4):747-761. doi: 10.1002/dta.2978.
|
3 |
The salmeterol anomaly and the need for a urine threshold. Drug Test Anal. 2022 Jun;14(6):997-1003. doi: 10.1002/dta.2810.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.